The Megyn Kelly Show Inside the 409-Page Trump Administration Report Challenging "Gender-Affirming Care": AM Update 5/26
32 snips
May 26, 2025 A new comprehensive report critiques medical interventions for children with gender dysphoria, raising alarms about the use of puberty blockers and hormone therapies. Whistleblower Dr. Eithan Haim reveals potential misrepresentations in medical practices and highlights the risks of infertility and brain development issues. The discussion delves into the broader implications of these findings for Medicaid funding and challenges healthcare professionals face under current guidelines. Parents and policymakers are urged to reconsider established medical standards.
AI Snips
Chapters
Transcript
Episode notes
Report Criticizes Vague Language
- The 409-page HHS report challenges gender-affirming care, arguing it uses vague and medically inaccurate language.
- Terms like "sex assigned at birth" are labeled as deceptive euphemisms that obscure biological reality.
Puberty Blockers Are Not Reversible
- Puberty blockers are often called reversible, but the report says this is misleading and medically dishonest.
- The drugs cause permanent changes including infertility and altered brain development, not merely a pause in puberty.
Puberty Blockers Harsh on Children
- Puberty blockers, originally meant for prostate cancer, are difficult even for adults to tolerate.
- Dr. Eithan Haim stresses that giving this treatment to 11-year-old children is alarming due to its severe effects.